The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Artificial viruses: a nanotechnological approach to gene delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00445-3 · Cited by 2,329
Transport Between the Cell Nucleus and the Cytoplasm
Görlich, D., & Kutay, U. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.607 · Cited by 2,022
Luby-Phelps, K. (1999) · International Review of Cytology · doi:10.1016/s0074-7696(08)60527-6 · Cited by 1,149
High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
Capecchi, M. R. (1980) · Cell · doi:10.1016/0092-8674(80)90358-x · Cited by 1,001
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of ∼39 nm
Panté, N., & Kann, M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-06-0308 · Cited by 776
Zanta, M. A., Belguise-Valladier, P., & Behr, J.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.91 · Cited by 722
Gaspar, H. B., Parsley, K. L., Howe, S., King, D., Gilmour, K. C., Sinclair, J., Brouns, G., Schmidt, M., Von Kalle, C., Barington, T., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17590-9 · Cited by 689
Wagner, E., Plank, C., Zatloukal, K., Cotten, M., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7934 · Cited by 658
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer
Lechardeur, D., Sohn, K.-J., Haardt, M., Joshi, P. B., Monck, M., Graham, R. W., Beatty, B., Squire, J., O’Brodovich, H., & Lukacs, G. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300867 · Cited by 633
Towards safe, non-viral therapeutic gene expression in humans
Glover, D. J., Lipps, H. J., & Jans, D. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1577 · Cited by 598
DNA Complexes with Polycations for the Delivery of Genetic Material into Cells
Kabanov, A. V., & Kabanov, V. A. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00031a002 · Cited by 480
Efficient Gene Transfer Using Reversibly Cross-Linked Low Molecular Weight Polyethylenimine
Gosselin, M. A., Guo, W., & Lee, R. J. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0100455 · Cited by 454
Chiocca, E. A., Abbed, K. M., Tatter, S., Louis, D. N., Hochberg, F. H., Barker, F., Kracher, J., Grossman, S. A., Fisher, J. D., Carson, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.021 · Cited by 436
Chary, S. R., & Jain, R. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5385 · Cited by 411
Miyata, K., Kakizawa, Y., Nishiyama, N., Harada, A., Yamasaki, Y., Koyama, H., & Kataoka, K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0379666 · Cited by 394
Moss, R. B., Rodman, D., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D., Milla, C., Brody, A. S., Clancy, J. P., Ramsey, B., et al. (2004) · Chest · doi:10.1378/chest.125.2.509 · Cited by 390
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupicky, D., Barrett, L. B., Spice, R., Kendall, M., Berry, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni085 · Cited by 279
Rivera, V. M., Gao, G.-P., Grant, R. L., Schnell, M. A., Zoltick, P. W., Rozamus, L. W., Clackson, T., & Wilson, J. M. (2005) · Blood · doi:10.1182/blood-2004-06-2501 · Cited by 276
Plasmid DNA entry into postmitotic nuclei of primary rat myotubes.
Dowty, M. E., Williams, P., Zhang, G., Hagstrom, J. E., & Wolff, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4572 · Cited by 270
Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., & Harashima, H. (2004) · Biochemistry · doi:10.1021/bi035802w · Cited by 269
A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA
Ludtke, J. J., Zhang, G., Sebestyén, M. G., & Wolff, J. A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.12.2033 · Cited by 220
Actin Cytoskeleton as the Principal Determinant of Size-dependent DNA Mobility in Cytoplasm
Dauty, E., & Verkman, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412374200 · Cited by 215
Application of membrane-active peptides for nonviral gene delivery
Wagner, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00033-2 · Cited by 194
Optimization of transcriptional regulatory elements for constructing plasmid vectors
Xu, Z.-L., Mizuguchi, H., Ishii-Watabe, A., Uchida, E., Mayumi, T., & Hayakawa, T. (2001) · Gene · doi:10.1016/s0378-1119(01)00550-9 · Cited by 184
(2002) · Human Gene Therapy · doi:10.1089/10430340152712629 · Cited by 174
NLS bioconjugates for targeting therapeutic genes to the nucleus
Escriou, V., Carrière, M., Scherman, D., & Wils, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00184-9 · Cited by 164
Fasbender, A., Zabner, J., Zeiher, B., & Welsh, M. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300524 · Cited by 161
Cytoplasmic Dynein Mediates Adenovirus Binding to Microtubules
Kelkar, S., Pfister, K. K., Crystal, R. G., & Leopold, P. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10122-10132.2004 · Cited by 157
Oupický, D., Carlisle, R. C., & Seymour, L. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301446 · Cited by 151
Verbaan, F. J., Oussoren, C., Snel, C. J., Crommelin, D. J. A., Hennink, W. E., & Storm, G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.475 · Cited by 150
Self-citationMetselaar, J. M., de Bruin, P., de Boer, L. W. T., de Vringer, T., Snel, C. J., Oussoren, C., Wauben, M. H. M., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340363 · Cited by 150
Self-citationMakower, D., Rozenblit, A. M., Kaufman, H. L., Edelman, M. C., Lane, M. E., Zwiebel, J. A., Haynes, H., & Wadler, S. (2003) · PubMed · Cited by 148
Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids
Pollard, H., Toumaniantz, G., Amos, J.-L., Avet‐Loiseau, H., Guihard, G., Behr, J., & Escande, D. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.160 · Cited by 148
Chiu, S.-J., Ueno, N. T., & Lee, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.019 · Cited by 146
Gene Therapy for Severe Combined Immunodeficiency
Cavazzana, M., Lagresle‐Peyrou, C., Hacein‐Bey‐Abina, S., & Fischer, A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.090203.104142 · Cited by 146
Regulated gene expression systems
Clackson, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301120 · Cited by 134
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis
Kim, W. J., Yockman, J. W., Lee, M., Jeong, J. H., Kim, Y., & Kim, S. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.016 · Cited by 126
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
van Steenis, J. H., van Maarseveen, E. M., Verbaan, F. J., Verrijk, R., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00361-9 · Cited by 118
Self-citationMesika, A., Kiss, V., Brumfeld, V., Ghosh, G., & Reich, Z. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.200 · Cited by 117
Stopeck, A., Jones, A., Hersh, E. M., Thompson, J. A., Finucane, D., Gutheil, J. C., & Gonzalez, R. C. (2001) · PubMed · Cited by 111
The role of CpG motifs in immunostimulation and gene therapy
Scheule, R. K. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00090-9 · Cited by 109
Bremner, K. H., Seymour, L. W., Logan, A., & Read, M. L. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034140k · Cited by 99
Zuber, G., Zammut‐Italiano, L., Dauty, E., & Behr, J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250446 · Cited by 93
Saito, G., Amidon, G. L., & Lee, K.-D. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301859 · Cited by 77
Martínez‐Moreno, M., Navarro‐Lérida, I., Roncal, F., Albar, J. P., Alonso, C., Gavilanes, F., & Rodríguez‐Crespo, I. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00516-7 · Cited by 72
Photochemically Enhanced Gene Delivery of EGF Receptor-targeted DNA Polyplexes
Kloeckner, J., Prasmickaite, L., Høgset, A., Berg, K., & Wagner, E. (2004) · Journal of drug targeting · doi:10.1080/10611860410001723090 · Cited by 58
Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity
Edelman, G. M., Meech, R., Owens, G. C., & Jones, F. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3038 · Cited by 56
Modular protein engineering for non-viral gene therapy
Arı́s, A., & Villaverde, A. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.05.004 · Cited by 55
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells
Mastrobattista, E., Kapel, R. H., Eggenhuisen, M. H., Roholl, P. J. M., Crommelin, D. J. A., Hennink, W. E., & Storm, G. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700311 · Cited by 44
Self-citationHighly efficient transduction of endothelial cells by targeted artificial virus-like particles
Müller, K., Nahde, T., Fahr, A., Müller, R., & Brüsselbach, S. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700280 · Cited by 44
Controlling the kinetics of transgene expression by plasmid design
Yew, N. S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.009 · Cited by 43
Vaysse, L., Harbottle, R. P., Bigger, B., Bergau, A., Tolmachov, O. E., & Coutelle, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311894200 · Cited by 38
Molecular motors as drug delivery vehicles
Cohen, R. N., Rashkin, M. J., Wen, X., & Szoka, F. C. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.04.003 · Cited by 32
Development of plasmid and oligonucleotide nanometric particles
Dauty, E., Behr, J., & Remy, J.-S. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301759 · Cited by 27
Bergen, M., Chen, R. E., & Gonzalez, R. C. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.377 · Cited by 25
Cited by
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery
Li, Y., Maciel, D., Rodrigues, J., Shi, X., & Tomás, H. (2015) · Chemical Reviews · doi:10.1021/cr500131f · Cited by 478
Miyata, K., Nishiyama, N., & Kataoka, K. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15258k · Cited by 451
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Eskandari, S., Guerin, T., Toth, I., & Stephenson, R. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.013 · Cited by 381
Metadata
- Authors
- Mastrobattista, E., van der Aa, M. A. E. M., Hennink, W. E., & Crommelin, D. J. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-02
- Volume
- 5
- Issue
- 2
- Pages
- 115-121
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2139251684
- Cited by
- 346
- References
- 60
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.